RA

Rajashree Abhay Kulkarni

Active Director Designated Partner DIN 11029821
DIN 11029821 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajashree Abhay Kulkarni

Data last updated:

Rajashree Abhay Kulkarni is a Designated Partner at Ayushree Ayurvedic Hospital & Research Center Llp (since 2025).

DIN 11029821
Primary Designation Designated Partner
First Appointment 30 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 Mar 20252025Active

Board colleagues of Rajashree Abhay Kulkarni

NameDINCompanyDesignation
Abhay Narayan Kulkarni11029820Ayushree Ayurvedic Hospital & Research Center LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Ayushree Ayurvedic Hospital & Research Center Llp
Premium access

Shareholding and investment profile for Rajashree Abhay Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajashree Abhay Kulkarni

Rajashree Abhay Kulkarni currently holds 1 directorship: Ayushree Ayurvedic Hospital & Research Center Llp (Designated Partner, since 30 Mar 2025).

Rajashree Abhay Kulkarni was first appointed on 30 Mar 2025 as Designated Partner at Ayushree Ayurvedic Hospital & Research Center Llp.

The current boards of Rajashree Abhay Kulkarni's companies include Abhay Narayan Kulkarni (Ayushree Ayurvedic Hospital & Research Center Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available